✦ LIBER ✦

High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL) — a single-institution study

✍ Scribed by R. Scherrer; P. Bettelheim; K. Geissler; U. Jäger; P. Knöbl; P. A. Kyrle; K. Laczika; G. Mitterbauer; E. Neumann; B. Schneider; I. Schwarzinger; K. Lechner

Book ID: 105500538
Publisher: Springer
Year: 1994
Tongue: English
Weight: 626 KB
Volume: 69
Category: Article
ISSN: 0939-5555
DOI: 10.1007/bf02215951

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thymic adult T-cell acute lymphoblastic

Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group

✍ Baak, U; Gökbuget, N; Orawa, H; Schwartz, S; Hoelzer, D; Thiel, E; Burmeister, T 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 158 KB

Prospective comparison of two flow cytom

Prospective comparison of two flow cytometry methodologies for monitoring minimal residual disease in a multicenter treatment protocol of childhood acute lymphoblastic leukemia

✍ Drorit Luria; Eti Rosenthal; David Steinberg; Yona Kodman; Marina Safanaiev; Nin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

A randomized, controlled, double-blind,

A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)

✍ Elena J. Ladas; David J. Kroll; Nicholas H. Oberlies; Bin Cheng; Deborah H. Ndao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 1 views

Improved risk classification for risk-sp

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

✍ Bassan, R.; Spinelli, O.; Oldani, E.; Intermesoli, T.; Tosi, M.; Peruta, B.; Ros 📂 Article 📅 2009 🏛 American Society of Hematology 🌐 English ⚖ 449 KB

Allogeneic bone marrow transplantation (

Allogeneic bone marrow transplantation (BMT) for the treatment of children with very high risk acute lymphoblastic leukemia (ALL) in first remission (CR1)

✍ F. Boulad; P. Steinherz; N.A. Kernan; T.N. Small; V. Prasad; S. Prockop; A. Kolb 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Excellent therapeutic efficacy and minim

Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia : A 7-year follow-up study of the dana-farber cancer institute consortium protocol 87-01

✍ Deborah P. Waber; Brenda L. Shapiro; Sarah C. Carpentieri; Richard D. Gelber; Gu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 3 views

## Background: In the current study, the authors evaluated late neuropsychologic effects 7 years after diagnosis and the long-term survival in a cohort of patients treated for high-risk childhood acute lymphoblastic leukemia (all) with cranial radiation therapy. efficacy and toxicity were evaluated